Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst
Fierce Biotech
Thu, 08/31/23 - 10:55 am
Bristol Myers Squibb
Revlimid
Pomalyst
Multiple Myeloma
mezigdomide
Bristol Myers gets key FDA approval for bone marrow disease drug
BioPharma Dive
Wed, 08/30/23 - 09:54 am
Bristol Myers Squibb
FDA
Reblozyl
myelodysplastic syndromes
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
BMS backs $255m round for contract cell maker Cellares
Pharmaphorum
Thu, 08/24/23 - 10:22 am
Cellares
funding
cell therapy
Bristol Myers Squibb
Fierce Biotech Layoff Tracker 2023: Bayer-bought BlueRock makes cuts; Alaunos lets go 60% of teams
Fierce Biotech
Fri, 08/18/23 - 10:28 am
layoffs
Alaunos Therapeutics
BlueRock Therapeutics
Thermo Fisher
Bristol Myers Squibb
Atreca
Galera Therapeutics
Inovio
Salarius Pharmaceuticals
Karyopharm Therapeutics
Intergalatic Therapeutics
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
Another round of layoffs hits BMS, with 100+ people impacted after earnings miss
Fierce Pharma
Mon, 08/14/23 - 11:33 am
Bristol Myers Squibb
layoffs
BMS debuts ‘We Are Bristol Myers Squibb’ video
Medical Marketing and Media
Tue, 08/8/23 - 10:38 pm
Bristol Myers Squibb
branding
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
Eliquis: the cardio drug that cannot be beat
EP Vantage
Fri, 08/4/23 - 10:14 am
Bristol Myers Squibb
Eliquis
generics
Bristol Myers, BeiGene end legacy Celgene deal with settlement years after China ban
Fierce Pharma
Thu, 08/3/23 - 11:22 am
Bristol Myers Squibb
BeiGene
Celgene
Bristol Myers, AstraZeneca settle PD-1, CTLA-4 cancer immunotherapy patent suits for $510M
Fierce Pharma
Tue, 08/1/23 - 12:02 pm
Bristol Myers Squibb
AstraZeneca
cancer immunotherapy
legal
patents
Patent Infringement
Focus: Drugmakers go under the skin, skirting early US Medicare price negotiations
Reuters
Mon, 07/31/23 - 10:12 am
injectables
cancer
JNJ
Bristol Myers Squibb
Halozyme
drug pricing
BMS Reports Q2 Sales Miss Amid Generic Competition, Lowers Full-Year Guidance
BioSpace
Thu, 07/27/23 - 11:35 pm
Bristol Myers Squibb
earnings
Bristol Myers gets positive opinion from CHMP for Opdivo
Pharmaceutical Business Review
Mon, 07/24/23 - 10:20 am
Bristol Myers Squibb
Opdivo
CHMP
Europe
melanoma
Check out the most-seen pharma brand TV debuts of 2023
Medical Marketing and Media
Wed, 07/19/23 - 05:49 pm
TV ads
DTC advertising
Bayer
AbbVie
Bristol Myers Squibb
Lilly, Novo, BMS return to boost BGV's largest European biotech fund yet
Fierce Biotech
Thu, 07/13/23 - 10:15 am
Eli Lilly
Novo Holdings
Bristol Myers Squibb
venture capital
funding
BGV
Europe
FDA rejects Xspray's would-be rival to Bristol Myers' Sprycel on dosing, manufacturing concerns
Fierce Pharma
Wed, 07/12/23 - 09:35 am
Xspray Pharma
Eversana
Sprycel
Bristol Myers Squibb
Dasynoc
leukemia
Bristol Myers' Opdivo stages comeback in bladder cancer, teeing up 2 'Merck' showdowns
Fierce Pharma
Wed, 07/12/23 - 09:30 am
Bristol Myers Squibb
Opdivo
bladder cancer
Merck
BMS makes quickfire bets on neurodegeneration, paying $95M to exercise Evotec, Prothena options
Fierce Biotech
Tue, 07/11/23 - 10:13 am
Bristol Myers Squibb
neurodegenerative disease
Prothena
Alzheimer's disease
Evotec
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »